• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.基于干细胞的 Hypoxamir-210 递送至梗死心脏:对干细胞存活和梗死心脏功能保护的影响。
J Mol Med (Berl). 2012 Sep;90(9):997-1010. doi: 10.1007/s00109-012-0920-1. Epub 2012 May 31.
2
Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells.同时激活 miR-107/PDCD10 和 hypoxamir-210/Casp8ap2 及其在干细胞缺血预处理中的细胞保护作用。
Antioxid Redox Signal. 2012 Oct 15;17(8):1053-65. doi: 10.1089/ars.2012.4518. Epub 2012 May 23.
3
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.缺血预处理通过靶向半胱氨酸天冬氨酸蛋白酶 8 相关蛋白 2 增加 miR-210 表达从而增强干细胞的存活。
J Biol Chem. 2009 Nov 27;284(48):33161-8. doi: 10.1074/jbc.M109.020925. Epub 2009 Aug 31.
4
Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b.移植间充质干细胞通过外泌体转移 miR-125b 减少梗死心脏中的自噬通量。
Circ Res. 2018 Aug 17;123(5):564-578. doi: 10.1161/CIRCRESAHA.118.312758.
5
Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.携带有 QHREDGS 的自组装多肽作为心肌梗死后间充质干细胞移植的新型递送系统。
FASEB J. 2019 Jul;33(7):8306-8320. doi: 10.1096/fj.201801768RR. Epub 2019 Apr 10.
6
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.经微小RNA-133a改造的间充质干细胞可增强梗死心脏的心脏功能并提高细胞存活率。
J Cardiovasc Pharmacol. 2015 Mar;65(3):241-51. doi: 10.1097/FJC.0000000000000183.
7
Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.阿托伐他汀通过上调长链非编码 RNA H19 增强间充质干细胞来源的外泌体在急性心肌梗死中的治疗效果。
Cardiovasc Res. 2020 Feb 1;116(2):353-367. doi: 10.1093/cvr/cvz139.
8
mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction.miR-15a/15b 簇调节间充质干细胞的存活以提高其治疗心肌梗死的疗效。
J Am Heart Assoc. 2019 Jan 8;8(1):e010157. doi: 10.1161/JAHA.118.010157.
9
MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts.微小 RNA-21 是肌母细胞预处理中 IL-11/Stat3 抗凋亡信号通路的关键决定因素。
Cardiovasc Res. 2010 Oct 1;88(1):168-78. doi: 10.1093/cvr/cvq151. Epub 2010 May 24.
10
MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.微小RNA-377通过靶向血管内皮生长因子调控缺血心脏中间充质干细胞诱导的血管生成。
PLoS One. 2014 Sep 24;9(9):e104666. doi: 10.1371/journal.pone.0104666. eCollection 2014.

引用本文的文献

1
MicroRNA-210 Enhances Cell Survival and Paracrine Potential for Cardiac Cell Therapy While Targeting Mitophagy.微小RNA-210增强细胞存活及心脏细胞治疗的旁分泌潜能,同时靶向线粒体自噬。
J Funct Biomater. 2025 Apr 21;16(4):147. doi: 10.3390/jfb16040147.
2
Priming mesenchymal stem cells to develop "super stem cells".引导间充质干细胞发育成“超级干细胞”。
World J Stem Cells. 2024 Jun 26;16(6):623-640. doi: 10.4252/wjsc.v16.i6.623.
3
Dose-response relationship of MSCs as living Bio-drugs in HFrEF patients: a systematic review and meta-analysis of RCTs.间充质干细胞作为生物活性药物在射血分数降低的心力衰竭患者中的剂量反应关系:一项随机对照试验的系统评价和荟萃分析
Stem Cell Res Ther. 2024 Jun 13;15(1):165. doi: 10.1186/s13287-024-03713-4.
4
Endothelial progenitor cell-derived small extracellular vesicles for myocardial angiogenesis and revascularization.内皮祖细胞衍生的小细胞外囊泡用于心肌血管生成和血管重建。
J Clin Transl Res. 2022 Oct 31;8(6):476-487. eCollection 2022 Dec 29.
5
Nanotechnology in cardiac stem cell therapy: cell modulation, imaging and gene delivery.心脏干细胞治疗中的纳米技术:细胞调节、成像与基因递送。
RSC Adv. 2021 Oct 26;11(55):34572-34588. doi: 10.1039/d1ra06404e. eCollection 2021 Oct 25.
6
Regulation of miRNAs by Natural Antioxidants in Cardiovascular Diseases: Focus on SIRT1 and eNOS.天然抗氧化剂对心血管疾病中微小RNA的调控:聚焦于沉默信息调节因子1和内皮型一氧化氮合酶
Antioxidants (Basel). 2021 Mar 3;10(3):377. doi: 10.3390/antiox10030377.
7
Inhibitory effects of miRNAs in astrocytes on C6 glioma progression via connexin 43.miRNAs 在星形胶质细胞中通过连接蛋白 43 对 C6 神经胶质瘤进展的抑制作用。
Mol Cell Biochem. 2021 Jul;476(7):2623-2632. doi: 10.1007/s11010-021-04118-0. Epub 2021 Mar 3.
8
Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia.用外泌体治疗心肌缺血中的氧化应激。
Int J Mol Sci. 2021 Feb 9;22(4):1729. doi: 10.3390/ijms22041729.
9
Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective.从临床角度定义肺癌干细胞中miRNA的外泌体携带成分。
World J Stem Cells. 2020 Jun 26;12(6):406-421. doi: 10.4252/wjsc.v12.i6.406.
10
Cardiac shock wave therapy protects cardiomyocytes from hypoxia‑induced injury by modulating miR‑210.心脏冲击波治疗通过调节 miR-210 保护心肌细胞免受缺氧诱导的损伤。
Mol Med Rep. 2020 Feb;21(2):631-640. doi: 10.3892/mmr.2019.10892. Epub 2019 Dec 18.

本文引用的文献

1
Subcellular preconditioning of stem cells: mito-Cx43 gene targeting is cytoprotective via shift of mitochondrial Bak and Bcl-xL balance.细胞亚结构预处理干细胞:通过线粒体 Bak 和 Bcl-xL 平衡的转移,mito-Cx43 基因靶向具有细胞保护作用。
Regen Med. 2012 May;7(3):323-34. doi: 10.2217/rme.12.13.
2
Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells.同时激活 miR-107/PDCD10 和 hypoxamir-210/Casp8ap2 及其在干细胞缺血预处理中的细胞保护作用。
Antioxid Redox Signal. 2012 Oct 15;17(8):1053-65. doi: 10.1089/ars.2012.4518. Epub 2012 May 23.
3
Human cardiac stem cell differentiation is regulated by a mircrine mechanism.人类心脏干细胞的分化受微小RNA 调控。
Circulation. 2011 Mar 29;123(12):1287-96. doi: 10.1161/CIRCULATIONAHA.110.982918. Epub 2011 Mar 14.
4
Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.缝隙连接介导的骨髓基质细胞微小 RNA 的导入可以引起乳腺癌细胞的细胞周期静止。
Cancer Res. 2011 Mar 1;71(5):1550-60. doi: 10.1158/0008-5472.CAN-10-2372. Epub 2011 Feb 22.
5
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease.miR-210 作为一种治疗缺血性心脏病的新疗法。
Circulation. 2010 Sep 14;122(11 Suppl):S124-31. doi: 10.1161/CIRCULATIONAHA.109.928424.
6
Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas.二氮嗪通过靶向 Fas 增强 NF-κB 依赖性 miR-146a 表达从而促进间充质干细胞存活。
Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1077-82. doi: 10.1152/ajpheart.00212.2010. Epub 2010 Jul 23.
7
Preconditioning and stem cell survival.预处理和干细胞存活。
J Cardiovasc Transl Res. 2010 Apr;3(2):89-102. doi: 10.1007/s12265-009-9161-2. Epub 2009 Dec 22.
8
MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts.微小 RNA-21 是肌母细胞预处理中 IL-11/Stat3 抗凋亡信号通路的关键决定因素。
Cardiovasc Res. 2010 Oct 1;88(1):168-78. doi: 10.1093/cvr/cvq151. Epub 2010 May 24.
9
Microvesicles: mediators of extracellular communication during cancer progression.微小囊泡:癌症进展过程中细胞外通讯的介质。
J Cell Sci. 2010 May 15;123(Pt 10):1603-11. doi: 10.1242/jcs.064386.
10
MiR-210--micromanager of the hypoxia pathway.miR-210-缺氧通路的微小管理者。
Trends Mol Med. 2010 May;16(5):230-7. doi: 10.1016/j.molmed.2010.03.004. Epub 2010 Apr 29.

基于干细胞的 Hypoxamir-210 递送至梗死心脏:对干细胞存活和梗死心脏功能保护的影响。

Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function.

机构信息

Department of Pathology, University of Cincinnati, 231-Albert Sabin Way, Cincinnati, OH 45267, USA.

出版信息

J Mol Med (Berl). 2012 Sep;90(9):997-1010. doi: 10.1007/s00109-012-0920-1. Epub 2012 May 31.

DOI:10.1007/s00109-012-0920-1
PMID:22648522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3423492/
Abstract

This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of (PC)MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid ((miR)MSC) and functional recovery of the infarcted heart of rat transplanted with (PC)MSC or (miR)MSC was evaluated. Both (PC)MSC and (miR)MSC showed higher survival under lethal anoxia as compared to (non-PC)MSC and scramble-transfected MSC ((Sc)MSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both (PC)MSC and (miR)MSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and (PC)MSC or (miR)MSC (using (non-PC)MSC or (Sc)MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with (PC)MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with (non-PC)MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from (miR)MSC to host cardiomyocytes led to functional recovery of the ischemic heart.

摘要

本研究旨在验证我们的假设,即转染 miR-210 可模拟间充质干细胞(MSC)的缺血预适应(IPC)的生存效应,并且 MSC 移植有助于缺血性心脏的功能恢复,因为 miR-210 通过缝隙连接传递给宿主心肌细胞。通过 IPC 或基于纳米粒子的 miR-210 质粒转染(miR-MSC)实现 MSC 中的 miR-210 表达,并评估移植(PC)MSC 或(miR)MSC 的大鼠梗死心脏的功能恢复。与(非-PC)MSC 和 scramble 转染的 MSC(Sc-MSC)对照相比,(PC)MSC 和(miR)MSC 在致命缺氧下表现出更高的存活率,同时 CASP8AP2 表达降低。同样,(PC)MSC 和(miR)MSC 移植后均可更好地存活并加速缺血性心脏的功能恢复。为了验证我们的假设,即 MSC 将 miR-210 递送至宿主心肌细胞,体外共培养心肌细胞与(PC)MSC 或(miR)MSC(以(非-PC)MSC 或(Sc)MSC 作为对照)显示 miR-210 与缝隙连接连接蛋白-43 共定位。用庚醇预处理可阻断 miR-210 向心肌细胞的转移。此外,与与(非-PC)MSC 共培养的心肌细胞相比,与(PC)MSC 共培养的心肌细胞观察到更高的存活率,同时伴随着 CASP8AP2 的表达,这表明 miR-210 从 MSC 转移以保护宿主心肌细胞。在梗死心脏中 MSC 中的 miR-210 诱导促进了其移植后的存活。此外,直接从(miR)MSC 向宿主心肌细胞传递生存促进的 miR-210 可导致缺血性心脏的功能恢复。